Compare INKT & AFCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INKT | AFCG |
|---|---|---|
| Founded | 2017 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.6M | 54.9M |
| IPO Year | 2021 | 2020 |
| Metric | INKT | AFCG |
|---|---|---|
| Price | $10.93 | $2.40 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $35.00 | $5.75 |
| AVG Volume (30 Days) | 5.3K | ★ 199.9K |
| Earning Date | 01-01-0001 | 06-03-2026 |
| Dividend Yield | N/A | ★ 27.15% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $24,563,601.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.41 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.66 | $2.06 |
| 52 Week High | $76.00 | $8.55 |
| Indicator | INKT | AFCG |
|---|---|---|
| Relative Strength Index (RSI) | 37.06 | 53.29 |
| Support Level | $6.85 | $2.31 |
| Resistance Level | $11.65 | $2.58 |
| Average True Range (ATR) | 0.31 | 0.11 |
| MACD | -0.03 | 0.03 |
| Stochastic Oscillator | 4.25 | 94.14 |
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
Advanced Flower Capital Inc is a commercial mortgage REIT that provides institutional loans to cannabis operators in the U.S. Through the management team's deep network and related credit and cannabis expertise. The company originates, structures, and underwrites loans secured by quality real estate assets, license value, and cash flows.